Precision Microbiome Therapeutics to Enhance Cancer Immunotherapy

We are pleased to announce that Dr. Sin-Hyeog Im from Pohang University of Science and Technology, Korea will join Second Conjoint RIKEN – ISM 2026 as a speaker and give a presentation entitled “Precision Microbiome Therapeutics to Enhance Cancer Immunotherapy“. Dr. Sin-Hyeog Im, a leading expert in immunology and microbiome research, will discuss how precision…

Engineering Mitochondrial Stress Tolerance through Mitochondria-Targeted Nanocapsules: Perspectives on the Microbiota–Mitochondria Axis

Prof. Yuma Yamada from Hokkaido University, Japan, will present his recent research at the 2nd RIKEN-ISM Conjoint Meeting — Tokyo Microbiota 2026, taking place on September 24–25, 2026 in Tokyo, Japan. His talk, entitled Engineering Mitochondrial Stress Tolerance through Mitochondria-Targeted Nanocapsules: Perspectives on the Microbiota–Mitochondria Axis, explores the emerging links between mitochondrial biology and the…

Rapid, Single-Cell-Precision Profiling for Probiotic Quality and Source-Tracking

We are pleased to announce that Dr. Jian Xu from Qingdao Institute of BioEnergy and Bioprocess Technology, China will join Second Conjoint RIKEN – ISM 2026 as a speaker and give a presentation entitled “Rapid, Single-Cell-Precision Profiling for Probiotic Quality and Source-Tracking“. Dr. Jian Xu, Founding Director of the Single-Cell Center at CAS-QIBEBT, a pioneer…

The Microbiota–Muscle Axis in Aging: How Trimethylamine N-Oxide (TMAO) Remodels Mitochondria and Promotes Sarcopenia

We are pleased to announce that Dr. Ippei Shimizu from National Cerebral and Cardiovascular Center Research Institute, Japan will join Second Conjoint RIKEN – ISM 2026 as a speaker and give a presentation entitled “The Microbiota–Muscle Axis in Aging: How Trimethylamine N-Oxide (TMAO) Remodels Mitochondria and Promotes Sarcopenia“. Dr. Ippei Shimizu, a leader in cardiovascular…